Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
about
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
description
scientific article published on 21 April 2020
@en
name
Ceftolozane/Tazobactam for Tre ...... xperience (CEFTABUSE II Study)
@en
type
label
Ceftolozane/Tazobactam for Tre ...... xperience (CEFTABUSE II Study)
@en
prefLabel
Ceftolozane/Tazobactam for Tre ...... xperience (CEFTABUSE II Study)
@en
P2093
P356
P1476
Ceftolozane/Tazobactam for Tre ...... xperience (CEFTABUSE II Study)
@en
P2093
Alessandro Russo
Angela Raffaella Losito
Antonio Mastroianni
Antonio Vena
CEFTABUSE Study Group
Carlo Tascini
Claudio Maria Mastroianni
Claudio Viscoli
Cristina Mussini
Cristina Rovelli
P304
P356
10.1093/OFID/OFAA139
P577
2020-04-21T00:00:00Z